Actively hiring
Clinical Trial Services (CRO)
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$32.4M
1 round on record
Latest round
$32.4M
Series A · Sep 2026 · this month
The money's age
Fresh money
0 months since the last round · not hiring
Momentum
35/100
in the news, fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series A | Sep 2026 | $32.4M | Orange Capital Partners lead, RAISE France lead | TNW Investors-funding |
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

Generative AI Medical Writing Solution for Biotech, Life Sciences, Pharma & Medical Devices | Artos AI. Book a demo online.

Discover P95 full-service CRO clinical trial solutions. Experts in epidemiology and real-world evidence for vaccines and infectious…

Logo About Us About Us Technology News Contact About Us Reinventing Remote Robotic Surgery toMake Life-Saving Interventions Accessible to…

Allucent is a contract research organization that runs clinical trials for small and mid-sized biotechnology and pharmaceutical companies…

Humaneva Group is a clinical-research-focused organization that integrates patient care, scientific innovation, and data-driven approaches…

Lindus Health is an artificial intelligence native contract research organisation that runs clinical trials end to end. Founded in 2021 in…
News
Akkodis and Biolevate Partner to Accelerate AI-Powered Scientific, Regulatory and Technical Documentation in Highly Regulated Industries
Read more
Report
Biolevate raises €30M Series A and opens Boston office for its life sciences AI
Paris AI startup Biolevate has raised a €30M Series A co-led by Orange Ventures and RAISE France and opened a Boston office.
Read more
Report
Biolevate To Advance AI-Native Drug Discovery Workflows With NVIDIA BioNeMo Agent Toolkit
Biolevate, an AI-native knowledge platform company for life sciences, today announced it is building with the NVIDIA BioNeMo Agent Toolkit to support the next phase of its agentic discovery roadmap.
Read more
Report
Biolevate's raises €6M to helps medical writers keep up with the pace of new drugs
Writing the documentation that must go alongside the development of new drugs is a highly labor-intensive process: not much software is used and there's a
Read more
Report
Financials
Total raised
$32.4M
Latest round
Series A
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Series A | 2026 | $32.4M | Details |






